Nan Fung Trinity’s Tourmaline Bio TRML Stock Holding History

Nan Fung Trinity’s Portfolio TRML Stock Details TRML Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-227,090	Closed	-$10.9M	–	88
2025 Q3	$10.9M	Hold	227,090	–	–	1.08%	38
2025 Q2	$3.63M	Buy	+227,090	New	+$3.68M	0.43%	49

Nan Fung Trinity's TRML Position: Q4 2025 in Review

Nan Fung Trinity sold out of Tourmaline Bio (TRML) in Q4 2025, closing a stake of 227,090 shares — an estimated $10.9M sold.

Nan Fung Trinity first reported a position in TRML in Q2 2025 and held it in 2 quarters. The position peaked at $10.9M in Q3 2025. 0 funds tracked by Wall St. Rank hold TRML as of Q4 2025.

Nan Fung Trinity reported no remaining Tourmaline Bio position as of Q4 2025 after selling out during the quarter.
Nan Fung Trinity sold 227,090 Tourmaline Bio shares in Q4 2025, an estimated $10.9M.
Nan Fung Trinity first reported a position in Tourmaline Bio in Q2 2025 and held it in 2 quarters.
Nan Fung Trinity's Tourmaline Bio position peaked at $10.9M in Q3 2025.
0 funds tracked by Wall St. Rank held Tourmaline Bio as of Q4 2025.

Based on Nan Fung Trinity's 13F filing for Q4 2025, filed 4 Feb 2026.